Molex Reiterated at Buy and 3 Reiterated Ratings to Know Now

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on January 2nd.

Synergy Pharma (NYSE:SGYP): Cantor Fitzgerald reiterated its rating of Buy for this company and changed its price target from $7 to $13.

Molex (NASDAQ:MOLX): Deutsche Bank reiterated its rating of Buy for this company and changed its price target from $29 to $32.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Amphenol (NYSE:APH): Deutsche Bank reiterated its rating of Buy for this company and changed its price target from $70 to $73.

Exelon (NYSE:EXC): UBS reiterated its rating of Neutral for this company and changed its price target from $29 to $28.

Don’t Miss: Will the Fiscal Cliff Enhance the January Effect?